CO6270206A2 - Producto de dispersion solida de drogas basadas en n-aril urea - Google Patents

Producto de dispersion solida de drogas basadas en n-aril urea

Info

Publication number
CO6270206A2
CO6270206A2 CO10049271A CO10049271A CO6270206A2 CO 6270206 A2 CO6270206 A2 CO 6270206A2 CO 10049271 A CO10049271 A CO 10049271A CO 10049271 A CO10049271 A CO 10049271A CO 6270206 A2 CO6270206 A2 CO 6270206A2
Authority
CO
Colombia
Prior art keywords
solid dispersion
dispersion product
pharmaceutically acceptable
agent
matrix forming
Prior art date
Application number
CO10049271A
Other languages
English (en)
Spanish (es)
Inventor
Rudolf Schroeder
Tanja Heitermann
Original Assignee
Abbot Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbot Gmbh & Co Kg filed Critical Abbot Gmbh & Co Kg
Publication of CO6270206A2 publication Critical patent/CO6270206A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO10049271A 2007-10-19 2010-04-27 Producto de dispersion solida de drogas basadas en n-aril urea CO6270206A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99961807P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
CO6270206A2 true CO6270206A2 (es) 2011-04-20

Family

ID=40089463

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10049271A CO6270206A2 (es) 2007-10-19 2010-04-27 Producto de dispersion solida de drogas basadas en n-aril urea

Country Status (18)

Country Link
EP (1) EP2197425A2 (fr)
JP (1) JP2011500649A (fr)
KR (1) KR20100087170A (fr)
CN (1) CN101827584A (fr)
AU (1) AU2008313622A1 (fr)
BR (1) BRPI0818340A2 (fr)
CA (1) CA2699301A1 (fr)
CO (1) CO6270206A2 (fr)
CR (1) CR11442A (fr)
DO (1) DOP2010000117A (fr)
EC (1) ECSP10010183A (fr)
GT (1) GT201000102A (fr)
MX (1) MX2010004291A (fr)
PA (1) PA8800101A1 (fr)
RU (1) RU2010119929A (fr)
UA (1) UA100865C2 (fr)
WO (1) WO2009050291A2 (fr)
ZA (1) ZA201002095B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009100176A2 (fr) * 2008-02-07 2009-08-13 Abbott Laboratories Forme pharmaceutique pour administration orale d’un inhibiteur de tyrosine kinase
AR077975A1 (es) 2009-08-28 2011-10-05 Irm Llc Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
MX2012014387A (es) * 2010-06-09 2013-05-01 Abbvie Inc Dispersiones solidas que contienen inhibidores de cinasa.
CA2855243C (fr) 2011-11-11 2020-04-14 Novartis Ag Procede de traitement d'une maladie proliferative
LT2782557T (lt) * 2011-11-23 2018-12-27 Array Biopharma, Inc. Farmacinės kompozicijos
WO2014003677A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant des particules de dispersion solide contenant du tadalafil
WO2014003678A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant de l'ambrisentan et des particules de dispersion solide contenant du tadalafil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
WO2007066189A2 (fr) * 2005-12-09 2007-06-14 Pfizer Products Inc. Sels, promedicaments et formulations de 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-uree
EP2089003A1 (fr) * 2006-11-09 2009-08-19 Abbott GmbH & Co. KG Forme de dosage pharmaceutique pour l'administration orale d'un inhibiteur de la tyrosine kinase

Also Published As

Publication number Publication date
DOP2010000117A (es) 2010-05-15
WO2009050291A2 (fr) 2009-04-23
BRPI0818340A2 (pt) 2015-04-22
UA100865C2 (ru) 2013-02-11
ZA201002095B (en) 2011-11-30
CA2699301A1 (fr) 2009-04-23
PA8800101A1 (es) 2009-05-15
JP2011500649A (ja) 2011-01-06
EP2197425A2 (fr) 2010-06-23
CR11442A (es) 2010-09-06
CN101827584A (zh) 2010-09-08
WO2009050291A3 (fr) 2010-04-08
RU2010119929A (ru) 2011-11-27
AU2008313622A1 (en) 2009-04-23
KR20100087170A (ko) 2010-08-03
MX2010004291A (es) 2010-08-02
GT201000102A (es) 2012-03-12
ECSP10010183A (es) 2010-06-29

Similar Documents

Publication Publication Date Title
CO6270206A2 (es) Producto de dispersion solida de drogas basadas en n-aril urea
DOP2010000114A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea
Kurakula et al. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition
US10632074B2 (en) Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product
AR001458A1 (es) Composición farmacéutica para la administración transdérmica.
MX2015012433A (es) Matriz de microestructura para suministro de agentes activos.
PE20071139A1 (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
AR077411A2 (es) Forma de dosificacion farmaceutica solida, con lopinavir y ritonavir, y proceso para su preparacion.
RU2004137118A (ru) Фармацевтическая композиция для контролируемого высвобождения активных веществ и способ ее изготовления
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
ES2183602T3 (es) Formulaciones microencapsuladas.
AR080736A1 (es) Composicion farmaceutica de disolucion rapida, usualmente bucodispersable, y proceso para prepararla
RU2488384C2 (ru) Композиции для лечения неопластических заболеваний
AR045193A1 (es) Composicion de fexofenadina y proceso de preparacion
JP2010536837A5 (fr)
MX2023003556A (es) Composiciones farmaceuticas.
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
UA83036C2 (ru) Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ
AR048432A1 (es) Composiciones diureticas de liberacion prolongada
PE20110923A1 (es) Formulaciones de desintegracion rapida pre-compactadas de compuestos con baja biodisponibilidad oral
AR078167A1 (es) Dispersion solida que comprende un agente anti-vih
CO6270249A2 (es) Fibra, pelicula o espuma que comprende un plastificador y un gel ligado a arcilla cargado y metodos para su produccion
CA3130171C (fr) Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l'amitriptyline
Charoensumran Development of Polystyrene-based Organogels Swollen in D-limonene for Transdermal Drug Delivery
TH144451A (th) อนุภาคเชิงซ้อนของสารที่ถูกฉีดเมื่ออยู่ในสภาวะหลอมละลาย

Legal Events

Date Code Title Description
FC Application refused